Drug-eluting coronary stents – focus on improved patient outcomes

References

• GruentzigARKingSB3rdSchlumpfMSiegenthalerWLong-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experienceN Engl J Med198731618112711322952877
   PubMed Web of Science ®Google Scholar
• de FeyterPJde JaegerePPSerruysPWIncidence, predictors, and management of acute coronary occlusion after coronary angioplastyAm Heart J199412736436518122614
   PubMed Web of Science ®Google Scholar
• SerruysPWStraussBHBeattKJAngiographic follow-up after placement of a self-expanding coronary-artery stentN Engl J Med1991324113171984159
   PubMed Web of Science ®Google Scholar
• BoersmaEAkkerhuisKMTherouxPCaliffRMTopolEJSimoonsMLPlatelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary interventionCirculation1999100202045204810562258
   PubMed Web of Science ®Google Scholar
• LiuMWRoubinGSKingSB3rdRestenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasiaCirculation1989796137413872524293
   PubMed Web of Science ®Google Scholar
• VirmaniRFarbAPathology of in-stent restenosisCurr Opin Lipidol199910649950610680043
   PubMed Web of Science ®Google Scholar
• BertrandOFSipehiaRMongrainRBiocompatibility aspects of new stent technologyJ Am Coll Cardiol19983235625719741494
   PubMed Web of Science ®Google Scholar
• KastratiAMehilliJDirschingerJIntracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trialCirculation2001103232816282111401938
   PubMed Web of Science ®Google Scholar
• KereiakesDJCoxDAHermillerJBUsefulness of a cobalt chromium coronary stent alloyAm J Cardiol200392446346612914881
   PubMed Web of Science ®Google Scholar
• TamaiHIgakiKKyoEInitial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humansCirculation2000102439940410908211
   PubMed Web of Science ®Google Scholar
• PinchukLWilsonGJBarryJJMedical applications of poly(styrene-block-isobutylene-block-styrene) (“SIBS”)Biomaterials200829444846017980425
   PubMed Web of Science ®Google Scholar
• PinchukLA review of the biostability and carcinogenicity of polyurethanes in medicine and the new generation of ‘biostable’ polyurethanesJ Biomater Sci Polym Ed1994632252677986779
   PubMed Web of Science ®Google Scholar
• VirmaniRGuagliumiGFarbALocalized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?Circulation2004109670170514744976
   PubMed Web of Science ®Google Scholar
• KimJWSeoHSParkJHA prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunctionJ Am Coll Cardiol200953181653165919406340
   PubMed Web of Science ®Google Scholar
• CostaJRJrAbizaidACostaR1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trialJACC Cardiovasc Interv20092542242719463465
   PubMed Web of Science ®Google Scholar
• SousaJESousaAGCostaMAAbizaidACFeresFUse of rapamycin-impregnated stents in coronary arteriesTransplant Proc2003353 Suppl165S170S12742491
   PubMed Web of Science ®Google Scholar
• SchiffPBFantJHorwitzSBPromotion of microtubule assembly in vitro by taxolNature19792775698665667423966
   PubMed Web of Science ®Google Scholar
• MarxSOMarksARBench to bedside: the development of rapamycin and its application to stent restenosisCirculation2001104885285511514367
   PubMed Web of Science ®Google Scholar
• KimJSJangIKKimJSOptical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stentsHeart200995231907191219535352
   PubMed Web of Science ®Google Scholar
• VerheyeSAgostoniPDuboisCL9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) studyJ Am Coll Cardiol200953121031103919298915
   PubMed Web of Science ®Google Scholar
• HwangCWWuDEdelmanERPhysiological transport forces govern drug distribution for stent-based deliveryCirculation2001104560060511479260
   PubMed Web of Science ®Google Scholar
• HwangCWWuDEdelmanERImpact of transport and drug properties on the local pharmacology of drug-eluting stentsInt J Cardiovasc Intervent20035171212623559
   PubMedGoogle Scholar
• AcharyaGParkKMechanisms of controlled drug release from drug-eluting stentsAdv Drug Deliv Rev200658338740116546289
   PubMed Web of Science ®Google Scholar
• RanadeSVMillerKMRichardREChanAKAllenMJHelmusMNPhysical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stentJ Biomed Mater Res A200471462563415514926
   PubMed Web of Science ®Google Scholar
• TaylorAJGormanPDKenwoodBHudakCTashkoGVirmaniRA comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine modelCatheter Cardiovasc Interv200153342042511458427
   PubMed Web of Science ®Google Scholar
• SchwartzRSEdelmanERCarterADrug-eluting stents in preclinical studies: recommended evaluation from a consensus groupCirculation2002106141867187312356643
   PubMed Web of Science ®Google Scholar
• SousaJECostaMAAbizaidALack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound studyCirculation2001103219219511208675
   PubMed Web of Science ®Google Scholar
• MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med2002346231773178012050336
   PubMed Web of Science ®Google Scholar
• HolmesDRJrLeonMBMosesJWAnalysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosisCirculation2004109563464014769686
   PubMed Web of Science ®Google Scholar
• WeiszGLeonMBHolmesDRJrFive-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) TrialJ Am Coll Cardiol200953171488149719389558
   PubMed Web of Science ®Google Scholar
• LemosPASerruysPWvan DomburgRTUnrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryCirculation2004109219019514691037
   PubMed Web of Science ®Google Scholar
• SerruysPWOnumaYGargS5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesionsJ Am Coll Cardiol201055111093110120171036
   PubMed Web of Science ®Google Scholar
• SabateMJimenez-QuevedoPAngiolilloDJRandomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trialCirculation2005112142175218316203930
   PubMed Web of Science ®Google Scholar
• MarestaAVaraniEBalducelliMComparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study)Am J Cardiol2008101111560156618489933
   PubMed Web of Science ®Google Scholar
• BaumgartDKlaussVBaerFOne-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patientsJ Am Coll Cardiol200750171627163417950142
   PubMed Web of Science ®Google Scholar
• Diaz de la LleraLSBallesterosSNevadoJSirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplastyAm Heart J.20071541164. e1e617584571
   PubMed Web of Science ®Google Scholar
• van der HoevenBLLiemSSJukemaJWSirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention StudyJ Am Coll Cardiol200851661862618261680
   PubMed Web of Science ®Google Scholar
• AtaryJZvan der HoevenBLLiemSSThree-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study)Am J Cardiol2010106141220609639
   PubMed Web of Science ®Google Scholar
• Di LorenzoEDe LucaGSauroRThe PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized TrialJACC Cardiovasc Interv20092651552319539255
   PubMed Web of Science ®Google Scholar
• Di LorenzoESauroRVarricchioABenefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trialAm Heart J20091584e43e5019781402
   PubMed Web of Science ®Google Scholar
• MenichelliMParmaAPucciERandomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)J Am Coll Cardiol200749191924193017498576
   PubMed Web of Science ®Google Scholar
• VioliniRMustoCDe FeliceFMaintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trialJ Am Coll Cardiol201055881081420170821
   PubMed Web of Science ®Google Scholar
• ValgimigliMPercocoGMalaguttiPTirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trialJAMA2005293172109211715870414
   PubMed Web of Science ®Google Scholar
• TebaldiMArcozziCCampoGThe 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarctionJ Am Coll Cardiol200954201900190119892243
   PubMed Web of Science ®Google Scholar
• SpauldingCHenryPTeigerESirolimus-eluting versus uncoated stents in acute myocardial infarctionN Engl J Med2006355111093110416971716
   PubMed Web of Science ®Google Scholar
• SpauldingCTeigerECommeauPFour-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty)JACC Cardiovasc Interv201141142321251624
   PubMed Web of Science ®Google Scholar
• RubartelliPPetronioASGuiducciVComparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trialEur Heart J201031162014202020566487
   PubMed Web of Science ®Google Scholar
• VermeerschPAgostoniPVerheyeSRandomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC TrialJ Am Coll Cardiol200648122423243117174178
   PubMed Web of Science ®Google Scholar
• VermeerschPAgostoniPVerheyeSIncreased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC TrialJ Am Coll Cardiol200750326126717631219
   PubMed Web of Science ®Google Scholar
• HakeemAHelmyTLeesarMArifIDrug-eluting stents for saphenous vein graft lesionsJACC Cardiovasc Interv.201145590 author reply 591–593.21596336
   PubMed Web of Science ®Google Scholar
• MehilliJRichardGNeumannFJIs Drug-Eluting Stenting Associated With Improved Results in Coronary Artery Bypass Grafts (ISAR CABG) trialPresented at American College of Cardiology Scientific SessionsApril 3–5, 2010New Orleans, LA
   Google Scholar
• GrubeESilberSHauptmannKETAXUS I: six- and twelvemonth results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesionsCirculation20031071384212515740
   PubMed Web of Science ®Google Scholar
• GrubeEDawkinsKGuagliumiGTAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesionsEuroIntervention20094557257719378676
   PubMed Web of Science ®Google Scholar
• SilberSColomboABanningAPFinal 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesionsCirculation2009120151498150419786634
   PubMed Web of Science ®Google Scholar
• ColomboADrzewieckiJBanningARandomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesionsCirculation2003108778879412900339
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGCoxDAA polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseN Engl J Med2004350322123114724301
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGCannonLComparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trialJAMA2005294101215122316160130
   PubMed Web of Science ®Google Scholar
• EllisSGStoneGWCoxDALong-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)JACC Cardiovasc Interv20092121248125920129552
   PubMed Web of Science ®Google Scholar
• DawkinsKDGrubeEGuagliumiGClinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practiceCirculation2005112213306331316286586
   PubMed Web of Science ®Google Scholar
• StoneGWLanskyAJPocockSJPaclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionN Engl J Med2009360191946195919420364
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGColomboALong-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial ProgramJACC Cardiovasc Interv20114553054221596326
   PubMed Web of Science ®Google Scholar
• DaemenJTsuchidaKStefaniniGGTwo-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registryEuroIntervention20062333033719755309
   PubMedGoogle Scholar
• MoriceMCColomboAMeierBSirolimus- vs paclitaxel- eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trialJAMA2006295889590416493102
   PubMed Web of Science ®Google Scholar
• RaberLWohlwendLWiggerMFive-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization LATE trialCirculation2011123242819282821646500
   PubMed Web of Science ®Google Scholar
• SchomigADibraAWindeckerSA meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery diseaseJ Am Coll Cardiol200750141373138017903638
   PubMed Web of Science ®Google Scholar
• BirkmeierKAKastratiAByrneRAFive-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patientsCatheter Cardiovasc Interv201177449450120824758
   PubMed Web of Science ®Google Scholar
• LeeSWParkSWKimYHA randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitusJ Am Coll Cardiol200852972773318718419
   PubMed Web of Science ®Google Scholar
• LeeSWParkSWKimYHA randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trialJ Am Coll Cardiol200953981281319245976
   PubMed Web of Science ®Google Scholar
• DibraAKastratiAMehilliJPaclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patientsN Engl J Med2005353766367016105990
   PubMed Web of Science ®Google Scholar
• LeeJHKimHSLeeSWProspective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trialCatheter Cardiovasc Interv2008721253218412270
   PubMed Web of Science ®Google Scholar
• KimHSLeeJHLeeSWLong-term safety and efficacy of sirolimus- vs paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trialInt J Cardiol2011147225325719783056
   PubMed Web of Science ®Google Scholar
• MehilliJKastratiAByrneRAPaclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery diseaseJ Am Coll Cardiol200953191760176819422982
   PubMed Web of Science ®Google Scholar
• MehilliJDibraAKastratiARandomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vesselsEur Heart J200627326026616401670
   PubMed Web of Science ®Google Scholar
• AwataMNantoSUematsuMAngioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stentsJ Am Coll Cardiol200852978979018718430
   PubMed Web of Science ®Google Scholar
• KimJSJangIKFanCEvaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trialJACC Cardiovasc Interv20092121240124720129551
   PubMed Web of Science ®Google Scholar
• FajadetJWijnsWLaarmanGJRandomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphoryl-choline-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trialCirculation2006114879880616908773
   PubMed Web of Science ®Google Scholar
• FajadetJWijnsWLaarmanGJLong-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II studyEuroIntervention20106556256721044908
   PubMed Web of Science ®Google Scholar
• KandzariDELeonMBPopmaJJComparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trialJ Am Coll Cardiol200648122440244717174180
   PubMed Web of Science ®Google Scholar
• KandzariDEMauriLPopmaJJLate-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)JACC Cardiovasc Interv20114554355021596327
   PubMed Web of Science ®Google Scholar
• LeonMBMauriLPopmaJJA randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialJ Am Coll Cardiol201055654355420152559
   PubMed Web of Science ®Google Scholar
• SerruysPWOngATPiekJJA randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialEuroIntervention200511586519758878
   PubMedGoogle Scholar
• SerruysPWRuygrokPNeuznerJA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trialEuroIntervention20062328629419755303
   PubMedGoogle Scholar
• StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA2008299161903191318430909
   PubMed Web of Science ®Google Scholar
• StoneGWRizviANewmanWEverolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseN Engl J Med2010362181663167420445180
   PubMed Web of Science ®Google Scholar
• KedhiEJoesoefKSMcFaddenESecond-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialLancet2010375971020120920060578
   PubMed Web of Science ®Google Scholar
• ParkKWYoonJHKimJSEfficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trialAm Heart J.20091575811. e1e81719376305
   PubMed Web of Science ®Google Scholar
• SerruysPWSilberSGargSComparison of zotarolimus-eluting and everolimus-eluting coronary stentsN Engl J Med2010363213614620554978
   PubMed Web of Science ®Google Scholar
• MaluendaGLemesleGWaksmanRA critical appraisal of the safety and efficacy of drug-eluting stentsClin Pharmacol Ther200985547448019279567
   PubMed Web of Science ®Google Scholar
• NordmannAJBrielMBucherHCMortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysisEur Heart J200627232784281417020889
   PubMed Web of Science ®Google Scholar
• PfistererMBrunner-La RoccaHPBuserPTLate clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stentsJ Am Coll Cardiol200648122584259117174201
   PubMed Web of Science ®Google Scholar
• CamenzindEStegPGWijnsWStent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concernCirculation20071151114401455 discussion 145517344324
   PubMed Web of Science ®Google Scholar
• LagerqvistBJamesSKStenestrandULong-term outcomes with drug-eluting stents versus bare-metal stents in SwedenN Engl J Med2007356101009101917296822
   PubMed Web of Science ®Google Scholar
• MauriLHsiehWHMassaroJMHoKKD’AgostinoRCutlipDEStent thrombosis in randomized clinical trials of drug-eluting stentsN Engl J Med2007356101020102917296821
   PubMed Web of Science ®Google Scholar
• StettlerCWandelSAllemannSOutcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisLancet2007370959193794817869634
   PubMed Web of Science ®Google Scholar
• StoneGWMosesJWEllisSGSafety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsN Engl J Med200735610998100817296824
   PubMed Web of Science ®Google Scholar
• KirtaneAJGuptaAIyengarSSafety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studiesCirculation2009119253198320619528338
   PubMed Web of Science ®Google Scholar
• KastratiADibraASpauldingCMeta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarctionEur Heart J200728222706271317901079
   PubMed Web of Science ®Google Scholar
• GargSSerruysPWCoronary stents: current statusJ Am Coll Cardiol20105610 SupplS1S4220797502
   PubMed Web of Science ®Google Scholar
• RiveroFMorenoRBarrealesLLower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stentsEuroIntervention20084112413219112789
   PubMedGoogle Scholar
• RasmussenKMaengMKaltoftAEfficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trialLancet201037597201090109920231034
   PubMed Web of Science ®Google Scholar
• CamenzindEWijnsWMauriLRationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantationAm Heart J20091586902909. e519958855
   PubMed Web of Science ®Google Scholar
• SpertusJASalisburyACJonesPGConawayDJThompsonRCPredictors of quality-of-life benefit after percutaneous coronary interventionCirculation2004110253789379415596563
   PubMed Web of Science ®Google Scholar
• ParisiAFFollandEDHartiganPA comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME InvestigatorsN Engl J Med1992326110161345754
   PubMed Web of Science ®Google Scholar
• Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participantsLancet199735090764614689274581
   PubMed Web of Science ®Google Scholar
• DagenaisGRLuJFaxonDPEffects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart diseaseCirculation2011123141492150021444887
   PubMed Web of Science ®Google Scholar
• WeintraubWSSpertusJAKolmPEffect of PCI on quality of life in patients with stable coronary diseaseN Engl J Med2008359767768718703470
   PubMed Web of Science ®Google Scholar
• SetoTBTairaDABerezinRPercutaneous coronary revascularization in elderly patients: impact on functional status and quality of lifeAnn Intern Med20001321295595810858178
   PubMed Web of Science ®Google Scholar
• ZhangZKolmPBodenWEThe cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable anginaCirc Cardiovasc Qual Outcomes20114217218221304091
   PubMed Web of Science ®Google Scholar
• KimbleLPDunbarSBWeintraubWSMcGuireDBManzoSFStricklandOLSymptom clusters and health-related quality of life in people with chronic stable anginaJ Adv Nurs20116751000101121352270
   PubMed Web of Science ®Google Scholar
• BrorssonBBernsteinSJBrookRHWerkoLQuality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal populationHeart200287214014511796552
   PubMed Web of Science ®Google Scholar
• HuebWABellottiGde OliveiraSAThe Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenosesJ Am Coll Cardiol1995267160016057594092
   PubMed Web of Science ®Google Scholar
• HendersonRAPocockSJClaytonTCSeven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapyJ Am Coll Cardiol20034271161117014522473
   PubMed Web of Science ®Google Scholar
• BodenWEO’RourkeRATeoKKOptimal medical therapy with or without PCI for stable coronary diseaseN Engl J Med2007356151503151617387127
   PubMed Web of Science ®Google Scholar
• TIME InvestigatorsTrial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trialLancet2001358928695195711583747
   PubMed Web of Science ®Google Scholar
• NorrisCMSaundersLDGhaliWAHealth-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical managementCan J Cardiol200420121259126615494780
   PubMed Web of Science ®Google Scholar
• CutlipDEWindeckerSMehranRClinical end points in coronary stent trials: a case for standardized definitionsCirculation2007115172344235117470709
   PubMed Web of Science ®Google Scholar
• HirlekarRPatelMJainSKadamVDrug eluting coronary artery stentsCurr Drug Deliv20107542142720973760
   PubMedGoogle Scholar
• MosesJWLeonMBPopmaJJSIRIUS InvestigatorsSirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryN Engl J Med2003349141315132314523139
   PubMed Web of Science ®Google Scholar
• SuttorpMJLaarmanGJRahelBMPrimary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusionsCirculation2006114992192816908768
   PubMed Web of Science ®Google Scholar